Stellungnahme der DGVS und der DGIM zum Zeitpunkt des Screenings auf Hepatitis B gemäß Mutterschafts-Richtlinien (Mu-RL)

• Literatur

• 1 Brown RS, McMahon BJ, Lok ASF. et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatology 2016; 63: 319-333
• 2 Li W, Jia L, Zhao X. et al. Efficacy and safety of tenofovir in preventing mother-to-infant transmission of hepatitis B virus: A meta-analysis based on 6 studies from China and 3 studies from other countries. BMC Gastroenterology 2018; 18
• 3 Hyun MH, Lee YS, Kim JH. et al. Systematic review with meta-analysis: the efficacy and safety of tenofovir to prevent mother-to-child transmission of hepatitis B virus. Alimentary Pharmacology and Therapeutics 2017; 45: 1493-505
• 4 Pan CQ, Duan Z, Dai E. et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. New England Journal of Medicine 2016; 374: 2324-2334
• 5 European Association for the Study of the Liver (EASL). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology 2017; 67: 370-398
• 6 Terrault NA, Bzowej NH, Chang K-M. et al. AASLD Guidelines for Treatment of Chronic Hepatitis B. Hepatology 2016; 63: 261-283
• 7 World Health Organization. Prevention of mother-to-child transmission of hepatitis B virus: Guidelines on antiviral prophylaxis in pregnancy. Geneva: World Health Organization; 2020 Licence: CC BY-NC-SA 3.0 IGO
• 8 Marcellin P, Heathcote EJ, Buti M. et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med 2008; 359: 2442-2455
• 9 Ständige Impfkommission: Empfehlungen der Ständigen Impfkommission (STIKO) beim Robert Koch-Institut 2021. Epid Bull 2021; 34: 3-63
• 10 Lin Y, Liu Y, Ding G. et al. Efficacy of tenofovir in preventing perinatal transmission of HBV infection in pregnant women with high viral loads. Scientific Reports 2018; 8
• 11 Chen JZJQ, Liao ZW, Huang FL. et al. Efficacy and safety of tenofovir disoproxil fumarate in preventing vertical transmission of hepatitis B in pregnancies with high viral load. Scientific Reports 2017; 7
• 12 Jourdain G, Ngo-Giang-Huong N, Harrison L. et al. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B. New England Journal of Medicine 2018; 378: 911-923
• 13 Yang M, Qin Q, Fang Q. et al. Cesarean section to prevent mother-to-child transmission of hepatitis B virus in China: A meta-analysis. BMC Pregnancy and Childbirth 2017; 17: 303
• 14 Chen HL, Cai JY, Song YP. et al. Vaginal delivery and HBV mother to child transmission risk after immunoprophylaxis: A systematic review and a meta-analysis. Midwifery 2019; 74: 116-125
• 15 Pan CQ, Zou HB, Chen Y. et al. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis b surface antigen-positive women to their infants. Clinical Gastroenterology and Hepatology 2013; 11: 1349-1355
• 16 Hou J, Wang G, Wang F. et al. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update). Journal of Clinical and Translational Hepatology 2017; 5: 297-318
• 17 Hou J, Cui F, Ding Y. et al. Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus. Clinical Gastroenterology and Hepatology 2019; 17: 1929-1936.e1
• 18 Ehrhardt S, Xie C, Guo N. et al. Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: A review of the evidence. Clinical Infectious Diseases 2015; 60: 275-278
• 19 Hu X, Wang L, Xu F. Guides concerning tenofovir exposure via breastfeeding: A comparison of drug dosages by developmental stage. International Journal of Infectious Diseases 2019; 87: 8-12
• 20 Mofenson LM, Baggaley RC, Mameletzis I. Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding. Aids 2017; 31: 213-232
• 21 Mugwanya KK, John-Stewart G, Baeten J. Safety of oral tenofovir disoproxil fumarate-based HIV pre-exposure prophylaxis use in lactating HIV-uninfected women. Expert Opinion on Drug Safety 2017; 16: 867-871
• 22 Wen W-H, Chen H-L, Shih TT-F. et al. Long-term growth and bone development in children of HBV-infected mothers with and without fetal exposure to tenofovir disoproxil fumarate. J Hepatol 2020; 72: 1082-1087
• 23 Wang M, Bian Q, Zhu Y. et al. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load. Alimentary Pharmacology and Therapeutics 2019; 49: 211-217